• Exchange: FN Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharmaceuticals

KAN:SS

2.6800 SEK 0.0400 1.47%

As of 03:57:28 ET on 07/30/2014.

Snapshot for Kancera AB (KAN)

Open: 2.7300 Day's Range: 2.6700 - 2.7300 Volume: 39,724
Previous Close: 2.7200 52wk Range: 0.5140 - 10.0500 1-Yr Rtn: +318.45%

Stock Chart for KAN

No chart data available.
  • KAN:SS 2.6800
  • 1D
  • 1M
  • 1Y
2.7200
Interactive KAN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for KAN

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. OMX -
Earnings Per Share (ttm) -0.2200
Est. EPS -
Est. PEG Ratio -
Market Cap (M SEK) 268.05
Shares Outstanding (M) 98.55
30 Day Average Volume 376,860
Price/Book (mrq) 11.6325
Price/Sale (ttm) 49.8424
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/22/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for KAN

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for KAN

Kancera AB is a biotechnology company. The Company focuses on the development and sale of drug candidates that have the potential to cure or slow down the development of cancer.

Erik NerpinNon-Executive ChairmanThomas OlinChief Executive Officer
Martin NorinCSOLars Ahrlund-RichterCSO
More Company Profile & Key Executives for KAN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil